Therapy of Autoimmune Liver Disease


Autoimmune hepatitis is a disease in which the body’s own immune system attacks the liver and causes it to become inflamed. The disease is chronic, meaning it lasts many years. If untreated, it can lead to cirrhosis and liver failure. There are two forms of this disease. Autoimmune hepatitis is characteristically responsive to corticosteroids, often used in combination with azathioprine to obtain a steroid-sparing effect. Therefore, autoimmune liver diseases are presently treated by suppression of the immune response.


    Related Conference of Therapy of Autoimmune Liver Disease

    October 20-21, 2025

    39th World Congress on Heart Diseases

    Frankfurt, Germany
    November 13-14, 2025

    6th Global Summit on Heart Congress

    Paris, France
    November 19-20, 2025

    7th World Heart Congress

    Tokyo, Japan
    November 24-25, 2025

    36th Annual Cardiologists Conference

    Barcelona, Spain
    November 27-28, 2025

    32nd World Heartcare Summit

    Paris, France
    January 12-13, 2026

    12th International Heart Conference

    Dubai, UAE
    March 18-19, 2026

    15th World Heart Congress

    Paris, France
    March 23-24, 2026

    41st World Cardiology Conference

    London, UK
    April 08-29, 2026

    9th Annual Heart Rhythm Conference

    Vienna, Austria
    April 13-14, 2026

    9th World Heart and Brain Conference

    Tokyo, Japan
    May 14-15, 2026

    5th International Conference on Cardiology

    Rome, Italy
    May 21-22, 2026

    15th World Congress on Cardiology

    London, UK
    July 29-30, 2026

    30th World Cardiology Conference

    Paris, France

    Therapy of Autoimmune Liver Disease Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in